Sun Pharma acquires US-based Pharmalucence

Tags: Companies
Drug major Sun Pharmaceutical Industries has acquired US-based Pharmalucence Inc for an undisclosed amount.

Pharmalucence, which has sterile injectable capacity in the US, has been acquired by one of the subsidiaries of Sun Pharma, the Mumbai-based firm said in a statement today.

The company, however, did not disclose the financial details of the deal.

Earlier this year, Sun Pharma had acquired Ranbaxy Laboratories in an all-stock transaction with a total equity value of $3.2 billion along with debt of $800 million, taking the overall deal value to $4 billion.

Sun Pharma shares were trading at Rs 748.30, up 1.30 per cent from its previous close.

EDITORIAL OF THE DAY

  • RBI governor reveals simple facts and figures on the health of PSU banks

    RBI governor Raghuram Rajan has built a solid reputation of administering bitter pills to the discomfiture of the mandarins in New Delhi.

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Simon J Evenett

Pulling out all stops & Trump cards

Donald Trump, the Republican Party nominee for US president, is ...

Zehra Naqvi

Let others show you what they see

The power to imagine yourself in someone else’s shoes, to ...

Dharmendra Khandal

When it rains, this beetle starts rolling dung

On the buffer road of a forest, a small metallic ...